Introduction
Fulminant myocarditis is an uncommon, but severe cardiac inflammatory
disease that can be fatal. The disease is characterized by a severe and
sudden onset marked by a rapid progressive deterioration that can occur
within 2 or 3 days. The use of extracorporeal membrane oxygenation
(ECMO) is common; therefore, its application in fulminant myocarditis
has also increased. Several case reports indicated that mechanical
circulation support (MCS) devices, including ECMO, which provides full
circulatory support with time for the heart to recover. However, to our
knowledge, there are no reports of a patient with fulminant myocarditis
who subsequently recovered cardiac function after long-term asystole.